Over 90% of patients in the study were opioid free through the end of multimodal treatment with JOURNAVX--These data have been accepted for oral presentation at the American Academy of Pain Medicine ...

Vertex, Inc. (NASDAQ: VERX), a global provider of tax technology solutions, today announced that Chris Young, President and ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2025, and provided its full year 2026 financial ...

Anthropic upgraded Claude’s Excel and PowerPoint add-ins with shared context, reusable Skills, and cross-app workflows for business users.

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

Anthropic has upgraded its Claude AI model with new capabilities for Microsoft Excel and PowerPoint, marking a strategic move to expand its enterprise footprint and potentially challenging Microsoft’s ...

The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida. Designed as an ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

Twelve months ago, drugmakers came roaring into 2025, fueled by a massive year of growth that peaked in the fourth quarter of ...

ServiceTitan, Inc. (NASDAQ:TTAN) Q4 2026 Earnings Call Transcript March 12, 2026 ServiceTitan, Inc. misses on earnings expectations. Reported EPS is $-443.47752 EPS, expectations were $0.1762.

The world of AI image generation just got a whole lot faster. Google DeepMind has quietly rolled out Nano Banana 2, its ...

AI is driving transformation at leading-edge enterprises. Here are the pure-plays, hyperscalers, hardware manufacturers, software vendors, and consultanies helping CIOs realize their AI visions.